| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Galapagos NV: Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024 | 281 | GlobeNewswire (Europe) | Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T... ► Artikel lesen | |
| Fr | Celebrity Cruises verkauft zwei Galapagos-Schiffe und startet Neubau Xcel | 2 | touristik aktuell | ||
| 31.05. | Galapagos selects Adaptimmune T-cell therapy for $665M biobucks collab | 13 | FierceBiotech | ||
| 30.05. | Adaptimmune, Galapagos to collaborate on uza-cel T-cell therapy | 14 | Seeking Alpha | ||
| 30.05. | Galapagos NV: Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune's TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications | 249 | GlobeNewswire (Europe) | Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized... ► Artikel lesen | |
| 30.05. | Adaptimmune Therapeutics PLC: Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications | 369 | Newsfile | Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell therapy) produced on Galapagos' decentralized... ► Artikel lesen | |
| 17.05. | Galapagos enters deal to boost decentralised CAR-T therapy production | 22 | Pharmaceutical Technology | ||
| 16.05. | Galapagos NV: Galapagos creates new subscription right plans | 398 | GlobeNewswire (Europe) | Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new... ► Artikel lesen | |
| 16.05. | Galapagos, Blood Centers of America Enter Strategic CAR-T Mfg. Pact | 8 | Contract Pharma | ||
| 16.05. | GALAPAGOS NV - 6-K, Report of foreign issuer | 10 | SEC Filings | ||
| 16.05. | Galapagos jumps on collaboration with Blood Centers of America | 25 | Reuters | ||
| 15.05. | Galapagos, BCA to collaborate on CAR-T cell therapy production | 10 | Seeking Alpha | ||
| 15.05. | Galapagos NV: Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos' decentralized CAR-T manufacturing network in the U.S. | 300 | GlobeNewswire (Europe) | BCA's national network of blood centers will provide decentralized manufacturing services for Galapagos' CAR-T product candidates, close to cancer treatment centersCollaboration enables rapid deployment... ► Artikel lesen | |
| 06.05. | Earnings call: Galapagos outlines strategic focus in Q1 2024 results | 16 | Investing.com | ||
| 02.05. | Galapagos NV: Galapagos reports first quarter 2024 financial results | 486 | GlobeNewswire (Europe) | Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunologyExecuted agreements with BridGene... ► Artikel lesen | |
| 01.05. | GALAPAGOS NV - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.04. | Galapagos NV: Galapagos' shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024 | 376 | GlobeNewswire (Europe) | Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the company's Annual and Extraordinary Shareholders' Meetings (AGM... ► Artikel lesen | |
| 30.04. | Galapagos NV expected to post a loss of 13 cents a share - Earnings Preview | 8 | Reuters | ||
| 30.04. | Galapagos NV expected to post a loss of 14 cents a share - Earnings Preview | 3 | Reuters | ||
| 08.04. | GALAPAGOS NV - 6-K, Report of foreign issuer | 5 | SEC Filings |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 819 |
| RHEINMETALL | 495 |
| TUI | 483 |
| GAMESTOP | 463 |
| EVOTEC | 368 |
| DEUTSCHE LUFTHANSA | 364 |
| NEL | 339 |
| SNOWFLAKE | 299 |
| BAYER | 295 |
| TESLA | 280 |
| BYD | 263 |
| BASF | 210 |
| VOLKSWAGEN | 200 |
| DEUTSCHE TELEKOM | 187 |
| PORSCHE SE | 184 |
| APPLE | 181 |
| MERCEDES-BENZ | 162 |
| THYSSENKRUPP | 159 |
| ALLIANZ | 152 |
| DEUTSCHE BANK | 142 |
| BROADCOM | 134 |
| COMMERZBANK | 133 |
| PLUG POWER | 132 |
| RWE | 126 |
| MICROSOFT | 125 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
